CYCCP - Cyclacel Pharmaceuticals Inc
5.85
0 0%
Share volume: 0
Last Updated: 01-02-2025
PREVIOUS CLOSE
CHG
CHG%
$5.85
0.00
0.00%
View ratios
| Fiscal Date | 09-30-2024 | |
|---|---|---|
| Fiscal Quarter | Q3 2024 | |
| Report Date | 11-12-2024 | |
| Assets | ||
| Total Assets | 5.381 M | |
| Current Assets | 4.913 M | |
| Inventories | 0.000 | |
| Other Current Assets | 0.000 | |
| Short Term Investments | 0.000 | |
| Total Receivables | 0.000 | |
| Current Cash | 2.982 M | |
| Total Non-current Assets | 0.000 | |
| Property Plant Equipment | 4.000 K | |
| Other Assets | 464.000 K | |
| Intangible Assets | 0.000 | |
| Goodwill | 0.000 | |
| Liabilities and shareholders’ equity | ||
| Total Liabilities and shareholders’ equity | 5.381 M | |
| Total liabilities | 6.351 M | |
| Total current liabilities | 6.351 M | |
| Accounts Payable | 4.126 M | |
| Other liabilities | 0.000 | |
| Current long term debt | 0.000 | |
| Long term debt | 0.000 | |
| Other liabilities | 0.000 | |
| Minority interest | 0.000 | |
| Total Shareholder equity | -970.000 K | |
| Common stock | 436.505 M | |
| Retained earnings | -436.442 M |